Literature DB >> 16413495

Prediction of treatment outcome among patients with irritable bowel syndrome treated with group cognitive therapy.

Edward B Blanchard1, Jeffrey M Lackner, Rebecca Gusmano, Gregory D Gudleski, Kathryn Sanders, Laurie Keefer, Susan Krasner.   

Abstract

Using a sample of over 125 patients with irritable bowel syndrome (IBS) who were treated with cognitive therapy administered in small groups, we sought to predict end of treatment and 3-month follow-up improvement in two changes indices of gastrointestinal (GI) symptoms (Pain/Discomfort Index which assessed change in abdominal pain, abdominal tenderness and bloating and Bowel Regularity Index which assessed change in diarrhea and constipation). We also sought to predict scores on IBS specific quality of life (QOL) and overall level of psychological distress using the Global Severity Index (GSI) of the Brief Symptom Inventory (BSI). Significant, but modest, levels of prediction were found for prediction of improvement in GI symptoms (4-15% of variance). Stronger significant prediction was obtained for the QOL and global psychological distress measure with R(2)'s ranging from 0.36 to 0.50. A wide variety of demographic, GI symptom, psychological status and psychiatric status variables entered the final prediction equations.

Entities:  

Mesh:

Year:  2006        PMID: 16413495     DOI: 10.1016/j.brat.2005.01.003

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  11 in total

Review 1.  Diagnosis and management of IBS.

Authors:  Sarah Khan; Lin Chang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 46.802

Review 2.  Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.

Authors:  P Paré; Ronald Bridges; Malcolm C Champion; Subhas C Ganguli; James R Gray; E Jan Irvine; Victor Plourde; Pierre Poitras; Geoffrey K Turnbull; Paul Moayyedi; Nigel Flook; Stephen M Collins
Journal:  Can J Gastroenterol       Date:  2007-04       Impact factor: 3.522

3.  Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome.

Authors:  Jeffrey M Lackner; Gregory D Gudleski; Laurie Keefer; Susan S Krasner; Cathrine Powell; Leonard A Katz
Journal:  Clin Gastroenterol Hepatol       Date:  2010-02-17       Impact factor: 11.382

4.  Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome.

Authors:  Jeffrey M Lackner; James Jaccard
Journal:  Clin Gastroenterol Hepatol       Date:  2018-10-26       Impact factor: 11.382

5.  How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trial.

Authors:  Jeffrey M Lackner; James Jaccard; Susan S Krasner; Leonard A Katz; Gregory D Gudleski; Edward B Blanchard
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

Review 6.  Aspects of the non-pharmacological treatment of irritable bowel syndrome.

Authors:  Elsa Maria Eriksson; Kristina Ingrid Andrén; Göran Karl Kurlberg; Henry Ture Eriksson
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

Review 7.  Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.

Authors:  Robert R Edwards; Robert H Dworkin; Dennis C Turk; Martin S Angst; Raymond Dionne; Roy Freeman; Per Hansson; Simon Haroutounian; Lars Arendt-Nielsen; Nadine Attal; Ralf Baron; Joanna Brell; Shay Bujanover; Laurie B Burke; Daniel Carr; Amy S Chappell; Penney Cowan; Mila Etropolski; Roger B Fillingim; Jennifer S Gewandter; Nathaniel P Katz; Ernest A Kopecky; John D Markman; George Nomikos; Linda Porter; Bob A Rappaport; Andrew S C Rice; Joseph M Scavone; Joachim Scholz; Lee S Simon; Shannon M Smith; Jeffrey Tobias; Tina Tockarshewsky; Christine Veasley; Mark Versavel; Ajay D Wasan; Warren Wen; David Yarnitsky
Journal:  Pain       Date:  2016-09       Impact factor: 7.926

8.  Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J).

Authors:  Motoyori Kanazawa; Douglas A Drossman; Masae Shinozaki; Yasuhiro Sagami; Yuka Endo; Olafur S Palsson; Michio Hongo; William E Whitehead; Shin Fukudo
Journal:  Biopsychosoc Med       Date:  2007-03-03

9.  Predicting the outcome of a cognitive-behavioral group training for patients with unexplained physical symptoms: a one-year follow-up study.

Authors:  Lyonne N L Zonneveld; Yanda R van Rood; Cornelis G Kooiman; Reinier Timman; Adriaan van 't Spijker; Jan J V Busschbach
Journal:  BMC Public Health       Date:  2012-10-08       Impact factor: 3.295

10.  Prediction of symptomatic improvement after exposure-based treatment for irritable bowel syndrome.

Authors:  Brjánn Ljótsson; Erik Andersson; Perjohan Lindfors; Jeffrey M Lackner; Karin Grönberg; Katarina Molin; Johanna Norén; Karin Romberg; Evelyn Andersson; Timo Hursti; Hugo Hesser; Erik Hedman
Journal:  BMC Gastroenterol       Date:  2013-11-19       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.